Understanding how certain receptors affect immune responses to malaria

Role of TAM receptors in modulating humoral immunity against parasitic infections

NIH-funded research Rosalind Franklin Univ of Medicine & Sci · NIH-10860318

This study is looking at how certain receptors on B cells affect the immune response to malaria in people who get infected multiple times, with the hope of finding ways to help the body fight the disease better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRosalind Franklin Univ of Medicine & Sci NIH-funded
Lab location1 site (North Chicago, United States)
Project IDNIH-10860318 on NIH RePORTER

What this research studies

This research investigates how TAM receptors on B cells influence the immune response to malaria, particularly in individuals who experience repeated infections. It aims to uncover the mechanisms behind the suboptimal immune responses that fail to provide lasting protection against the disease. By using genetic and biochemical methods, the researchers will explore how hypoxia and these receptors contribute to the accumulation of specific immune cells that may hinder effective immunity. The ultimate goal is to develop new strategies to enhance the body's ability to fight malaria.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals living in malaria-endemic regions who have experienced multiple malaria infections.

Not a fit: Patients who have not been exposed to malaria or those with other unrelated health conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments that enhance the immune response against malaria, potentially reducing the disease's prevalence and severity.

How similar studies have performed: Previous research has shown promise in understanding immune responses to malaria, but this specific approach focusing on TAM receptors is relatively novel.

Where this research is happening

North Chicago, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.